USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
10 May 2023 | 02:45 PM GMT

The Power of Mental Health Improvement Tools: Showing Pharma Their Potential Across All Therapeutic Areas

Anchored by:

Carlos Rodarte
Co-founder & CEO
VERITEOS

Participants:

Carlos Rodarte Co-founder & CEOVeriteos
Carlos Rodarte
Co-founder & CEOVeriteos
Chris Cera CEOArcweb Technologies
Chris Cera
CEOArcweb Technologies
JC Muyl Head, digital product strategyCCS Medical
JC Muyl
Head, digital product strategyCCS Medical
Patrick Leyseele Founder3.life
Patrick Leyseele
Founder3.life
Renae Beaumont Associate Professor of PsychologyWeill Cornell Medicine
Renae Beaumont
Associate Professor of PsychologyWeill Cornell Medicine
Simon Miller International Partnerships DirectorHeadspace
Simon Miller
International Partnerships DirectorHeadspace

About this Meeting

Small, intimate and participant-led discussions tackling digital health challenges. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

While pharma is beginning to recognise the power utility of digital mental health tools, there remain open questions about how to integrate them across the pharma value chain. Digital health mental health tools can be integrated as a direct form of care, or as a companion to various pharma prescriptions as part of a whole-person care model. Pharma continues to explore models that balance narrowly defined and validated clinical outcomes improvement with broader health improvement. 

Join us for a brief discussion on how pharma can re-imagine mental wellbeing and its risks and opportunities for the current pharma model. The meeting will address the following: 

  • Which therapeutic areas are most likely to benefit from the inclusion of digital mental health approaches? To what extent can digital tools for mental health be used in different disease areas as part of whole-person care? 
  • What is the role of pharma in enabling access to well-being focused digital mental health solutions? Rather than focusing on digital solutions for treatment, how can we use digital to enhance mental health fitness?
  • What kinds of ROI should pharma be able to realise? What organisational challenges are likely to arise?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.